葛康香

[摘要] 目的 探讨对肿瘤患者化疗相关性肠梗阻行程序化内科综合治疗的应用效果。 方法 择取我院2015年4月～2016年4月收治的64例肿瘤患者作为研究对象，根据患者住院病床号码进行分组研究，分为对照组和实验组，各32例。对照组接受基础治疗，实验组则行程序化内科综合治疗，观察并比较两组的治疗效果、肠梗阻症状消除时间以及死亡率。 结果 实验组治疗有效率96.9%显著高于对照组78.1%，差异有统计学意义（P<0.05）。实验组肠梗阻消除时间显著低于对照组，差异有统计学意义（P<0.05）。 结论 对肿瘤患者化疗相关性肠梗阻行程序化内科治疗，不仅能够极大程度降低患者死亡率，同时，还能够在一定程度上缩短肠梗阻的持续时间。

[关键词] 肿瘤患者；化疗相关性肠梗阻；程序化；内科综合治疗；死亡率

[中图分类号] R574.2 [文献标识码] B [文章编号] 1673-9701（2017）07-0068-03

[Abstract] Objective To explore the application effect of programmed comprehensive medical treatment on cancer patients with chemotherapy-related intestinal obstruction. Methods 64 cancer patients with chemotherapy-related intestinal obstruction admitted in our hospital from April 2015 to April 2016 were chosen as the study subjects. The patients were divided into control group and experimental group， with 32 cases in each group， according to the inpatient bed numbers. The control group received the basic treatment， and the experimental group was given programmed comprehensive medical treatment. The therapeutic effect， intestinal obstruction elimination time and the risk of death between the two groups were observed and compared. Results The effective rate of the experimental group was 96.9% significantly higher than 78.1% in the control group， and the difference between the two groups was statistically significant（P<0.05）. The elimination time of intestinal obstruction in the experimental group was significantly lower than that in the control group， and the difference between the two groups was statistically significant（P<0.05）. Conclusion The programmed comprehensive medical treatment for cancer patients with chemotherapy-related intestinal obstruction can not only reduce the mortality of patients to a great extent， but also shorten the duration of intestinal obstruction to a certain extent.

[Key words] Tumor patients； Chemotherapy-related intestinal obstruction； Programmed； Comprehensive medical treatment； Mortality

由于患者出现一种或者是多种原发性肿瘤所引起不同程度的肠梗阻症状被临床称为恶性肠梗阻疾病，通常发生于终末期恶性肿瘤患者。目前，临床上由于癌性病变所造成的恶性肠梗阻症状十分普遍，目前，经过临床研究充分显示，其发生率可达20%左右[1-3]。出现恶性肠梗阻症状的原因与患者接受化疗药物的神经毒性存在密切关联，其是临床上一种较为常见的麻醉性肠梗阻，同时也被称作为动力性肠梗阻，是一种功能性肠梗阻病变[4，5]。通过对化疗相关性肠梗阻肿瘤患者行程序化内科治疗，将会导致患者出现不同程度的心理和生理方面等问题，严重影响患者的身体健康和生活质量[6]。本研究通过对肿瘤患者化疗相关性肠梗阻行程序化内科综合治疗，能够获取较为理想的治疗效果。现报道如下。

1 资料与方法

1.1 一般资料

本次研究在患者知情同意下开展，将2015年4月～2016年4月我院收治的64例肿瘤患者作为研究对象，根据住院病床号码进行分组，分为对照组和实验组，各32例，均为自愿参与配合本次研究。……